IL-1R1 signaling facilitates munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation

Journal of Investigative Dermatology

Volumn 133, Issue 6, 2013, Pages 1541-1549

  Uribe Herranz, Mireia ^a   Lian, Li Hua ^a   Hooper, Kirsten M ^a   Milora, Katelynn A ^a   Jensen, Liselotte E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1ALPHA;

ACANTHOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DERMATITIS; DRUG INDUCED DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; NEUTROPHIL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84878551422     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.512     Document Type: Article

References (29)

1. Barland CO, Zettersten E, Brown BS et al. (2004) Imiquimod-induced interleukin-1alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol 122:330-6
2. Bowcock AM, Shannon W, Du F et al. (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 10:1793-805
3. Cai Y, Shen X, Ding C et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35:596-610
4. El Malki K, Karbach SH, Huppert J et al. (2012) An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor A signaling. J Invest Dermatol 133:441-51
5. Fanti PA, Dika E, Vaccari S et al. (2006) Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 45:1464-5
6. Gilliet M, Conrad C, Geiges M et al. (2004) Psoriasis triggered by Toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 140:1490-5
7. Jensen LE (2010) Targeting the IL-1 family members in skin inflammation. Curr Opin Investig Drugs 11:1211-20
8. Kan Y, Okabayashi T, Yokota S-i et al. (2012) Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway. J Virology 86:10338-46
9. Kang K, Hammerberg C, Cooper KD (1996) Differential regulation of IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1. Exp Dermatol 5: 218-26
10. Lai Y, Di Nardo A, Nakatsuji T et al. (2009) Commensal bacteria regulate Tolllike receptor 3-dependent inflammation after skin injury. Nat Med 15:1377-82
11. Lew W, Lee E, Krueger JG (2004) Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. Br J Dermatol 150:668-76
12. Lian L-H, Milora K, Manupipatpong KK et al. (2012) The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of interleukin-36g. J Invest Dermatol 132:1346-53
13. Mee JB, Johnson CM, Morar N et al. (2007) The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 171:32-42
14. Munro WJ (1898) Note sur l'histopathologie du psoriasis. Ann Dermatol Syph 9:961-7
15. Olaru F, Jensen LE (2010a) Chemokine expression by human keratinocyte cell lines after activation of Toll-like receptors (TLRs). Exp Dermatol 19:e314-6
16. Olaru F, Jensen LE (2010b) Staphylococcus aureus stimulates neutrophil targeting chemokine expression in keratinocytes through an autocrine IL-1alpha signaling loop. J Invest Dermatol 130:1866-76
17. Patel U, Mark NM, Machler BC et al. (2011) Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism. Br J Dermatol 164:670-2
18. Rajan N, Langtry JAA (2006) Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol 31:140-1
19. Sanmiguel JC, Olaru F, Li J et al. (2009) Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways. Cell Signal 21:685-94
20. Schön MP, Schön M (2007) Imiquimod: mode of action. Br J Dermatol 157: 8-13
21. Schön MP, Schön M, Klotz K-N (2006) The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126:1338-47
22. Steffen C (2002) William John Munro and Munro's abscess, and Franz Kogoj and Kogoj's spongiform pustule. Am J Dermatopathol 24:364-8
23. Swindell WR, Johnston A, Carbajal S et al. (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS ONE 6:e18266
24. Tonel G, Conrad C, Laggner U et al. (2010) Cutting edge: a critical functional role for IL-23 in psoriasis. J Immunol 185:5688-91
25. van der Fits L, Mourits S, Voerman JSA et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836-45
26. Wu JK, Siller G, Strutton G (2004) Psoriasis induced by topical imiquimod. Australas J Dermatol 45:47-50
27. Yano S, Bann T, Walsh R et al. (2008) Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J Cell Physiol 214:1-13
28. Zaba LC, Suárez-Farinas M, Fuentes-Duculan J et al. (2009) Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124:e1395
29. Zhou X, Krueger JG, Kao M-CJ et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100- element oligonucleotide array. Physiol Genomics 13:69-78